Trending
April 21, 2025 Neurotech Appoints Beth Marsh as Chief Commercial OfficerApril 9, 2025 Next Health Expands with First Nashville Location in The GulchMarch 19, 2025 Paratek Pharmaceuticals to Acquire OptinoseMarch 19, 2025 Hyku Biosciences Appoints Keith Wilcoxen, PhD, as Chief Scientific OfficerMarch 13, 2025 Insilico Medicine Secures $110 Million Series E Financing
April 21, 2025 Neurotech Appoints Beth Marsh as Chief Commercial OfficerApril 9, 2025 Next Health Expands with First Nashville Location in The GulchMarch 19, 2025 Paratek Pharmaceuticals to Acquire OptinoseMarch 19, 2025 Hyku Biosciences Appoints Keith Wilcoxen, PhD, as Chief Scientific OfficerMarch 13, 2025 Insilico Medicine Secures $110 Million Series E Financing
Featured

April 21, 2025
Neurotech Appoints Beth Marsh as Chief Commercial Officer
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing... Read more »

April 9, 2025
Next Health Expands with First Nashville Location in The Gulch
Next Health, the world’s most advanced brand of health optimization and longevity centers, had made its Tennessee... Read more »

March 19, 2025
Paratek Pharmaceuticals to Acquire Optinose
BOSTON and YARDLEY, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals and Optinose, Inc... Read more »